Antonio S. Montecalvo Organogenesis Holdings Inc. (ORGO) insider trading activity

Antonio S. Montecalvo is Vice President, Health Policy of Organogenesis Holdings Inc.. Currently has a direct ownership of 196,680 shares of ORGO, which is worth approximately $1.03 Million. The most recent transaction as insider was on Feb 19, 2025, when has been sold 42,493 shares (Class A Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 197K

16.88% 3M change

15.68% 12M change

Total Value Held $1.03 Million

Antonio S. Montecalvo Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 19 2025	BUY Grant, award, or other acquisition	-	42,493 Added 17.77%	196,680 Class A Common Stock
Feb 16 2025	SELL Payment of exercise price or tax liability	$2,660 $3.7 p/Share	719 Reduced 0.46%	154,187 Class A Common Stock
Feb 15 2025	SELL Payment of exercise price or tax liability	$49,439 $3.7 p/Share	13,362 Reduced 7.94%	154,906 Class A Common Stock
Apr 01 2024	SELL Payment of exercise price or tax liability	$4,905 $2.8 p/Share	1,752 Reduced 1.03%	168,268 Class A Common Stock
Feb 21 2024	BUY Grant, award, or other acquisition	-	43,732 Added 20.46%	170,020 Class A Common Stock
Feb 16 2024	SELL Payment of exercise price or tax liability	$2,502 $3.48 p/Share	719 Reduced 0.57%	126,288 Class A Common Stock
Feb 15 2024	SELL Payment of exercise price or tax liability	$36,465 $3.68 p/Share	9,909 Reduced 7.24%	127,007 Class A Common Stock
Apr 01 2023	SELL Payment of exercise price or tax liability	$4,466 $2.13 p/Share	2,097 Reduced 1.51%	136,916 Class A Common Stock
Feb 22 2023	BUY Grant, award, or other acquisition	-	99,428 Added 41.7%	139,013 Class A Common Stock
Feb 16 2023	SELL Payment of exercise price or tax liability	$1,971 $2.75 p/Share	717 Reduced 1.78%	39,585 Class A Common Stock
Feb 15 2023	SELL Payment of exercise price or tax liability	$3,647 $2.92 p/Share	1,249 Reduced 3.01%	40,302 Class A Common Stock
Apr 01 2022	SELL Payment of exercise price or tax liability	$21,603 $7.89 p/Share	2,738 Reduced 6.18%	41,551 Class A Common Stock
Mar 10 2022	SELL Open market or private sale	$817,488 $8.39 p/Share	97,436 Reduced 68.75%	44,289 Class A Common Stock
Mar 10 2022	BUY Exercise of conversion of derivative security	$237,024 $3.46 p/Share	68,504 Added 32.59%	141,725 Class A Common Stock
Mar 09 2022	SELL Open market or private sale	$85,200 $8.52 p/Share	10,000 Reduced 12.02%	73,221 Class A Common Stock
Feb 16 2022	SELL Payment of exercise price or tax liability	$5,586 $7.78 p/Share	718 Reduced 0.86%	83,221 Class A Common Stock
Feb 15 2022	BUY Grant, award, or other acquisition	-	14,383 Added 14.63%	83,939 Class A Common Stock
Apr 01 2021	SELL Payment of exercise price or tax liability	$35,099 $19.83 p/Share	1,770 Reduced 2.48%	69,556 Class A Common Stock
Feb 16 2021	BUY Grant, award, or other acquisition	-	8,260 Added 10.38%	71,326 Class A Common Stock

ASM

Antonio S. Montecalvo

Vice President, Health Policy

Canton, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ORGO shares.

Notify only if

Value

Insider Trading

Get notified when an Organogenesis Holdings Inc. insider buys or sells ORGO shares.

Notify only if

Operation

Value

Type

News

Receive news related to Organogenesis Holdings Inc.

Track Activities on ORGO

Account